Litigation Details for TAKEDA PHARMACEUTICALS AMERICA, INC. v. APOTEX, INC. (D.N.J. 2021)
✉ Email this page to a colleague
TAKEDA PHARMACEUTICALS AMERICA, INC. v. APOTEX, INC. (D.N.J. 2021)
| Docket | ⤷ Try a Trial | Date Filed | 2021-06-25 |
| Court | District Court, D. New Jersey | Date Terminated | 2023-02-07 |
| Cause | 35:271 Patent Infringement | Assigned To | Kevin McNulty |
| Jury Demand | None | Referred To | Andre M. Espinosa |
| Parties | APOTEX, INC. | ||
| Patents | 8,114,874; 8,173,158; 9,493,470 | ||
| Attorneys | BRIAN JOHN FORSATZ | ||
| Firms | Saiber, LLC | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in TAKEDA PHARMACEUTICALS AMERICA, INC. v. APOTEX, INC.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for TAKEDA PHARMACEUTICALS AMERICA, INC. v. APOTEX, INC. (D.N.J. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-01-12 | 119 | Opinion | include nonhuman 12 Zou et al., U.S. Patent No. 8,114,874 (DE 64-5). …The patents-in-suit are Patent Nos. 9,493,470 (the “’470 patent”), 11,192,895 (the “’895 patent”), 11,192,897… 63) ’470 Patent = Patent No. 9,493,470 (DE 63-2) ’895 Patent = Patent No. 11,192,895 (DE…,192,897 (the “’897 patent”), and 11,384,086 (the “’086 patent”).1 These patents are directed to crystalline…, and ’897 patents—was consolidated with Civil Action No. 1:22-cv-06151, a parallel patent infringement | External link to document |
| 2021-12-26 | 36 | Answer to Amended Complaint | THE PATENTS-IN-SUIT 6. Apotex admits that U.S. Patent No. 9,493,470 (the “’470 patent”), … As to the Alleged Infringement of U.S. Patent No. 9,493,470 by Apotex 33. Apotex incorporates…purports to bring an action for patent infringement under the patent laws of the United States, 35 U.…470 patent. Apotex further admits that what appears to be an uncertified copy of the ’470 patent was …. Apotex admits that U.S. Patent No. 11,192,897 (the “’897 patent”), issued on December 7, 2021, | External link to document |
| 2022-03-31 | 47 | Letter | Order Concerning Claim Construction of U.S. Patent Nos. 9,493,470, 11,192,895, and 11,192,897. (Attachments… 2021 8 February 2023 2:21-cv-12998 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
